Mouse-anti human TGF-β antibodies are monoclonal antibodies developed in mice that specifically target human TGF-β. These antibodies are used in research and therapeutic applications to neutralize the activity of TGF-β and study its role in various biological processes and diseases . For example, the mouse monoclonal pan-TGF-β neutralizing antibody 1D11 has been shown to inhibit the TGF-β pathway in human basal cell-like breast carcinoma cells .
Mouse-anti human TGF-β antibodies are valuable tools in studying the TGF-β signaling pathway and its involvement in disease progression. They are used to investigate the effects of TGF-β inhibition on cell growth, differentiation, and immune responses . Additionally, these antibodies have therapeutic potential in treating diseases associated with dysregulated TGF-β signaling, such as cancer and fibrosis .